The appellant appealed a decision of the Consent and Capacity Board finding him incapable of consenting to treatment with antipsychotic medication under the Health Care Consent Act, 1996.
The court considered whether the Board lacked jurisdiction due to panel composition, the proper legal test for capacity under s. 4(1) of the Act, the applicable standard of review, and whether the Board’s application of the test was reasonable.
The court held that tribunal expertise justified deference regardless of the individual qualifications of panel members and that the standard of review for the Board’s application of law to facts was reasonableness.
The Board reasonably concluded that although the appellant could understand relevant information, symptoms described as perseveration and grandiosity prevented him from appreciating the reasonably foreseeable consequences of refusing treatment.
The Board’s decision fell within a range of defensible outcomes and was upheld.